Common allergies in urban adolescents and their relationships with asthma control and healthcare utilization

• Research Open Access

• Hyekyun Rhee

• ,
• Tanzy Love,
• Donald Harrington and
• Annette Grape

Allergy, Asthma & Clinical Immunology201814:33

Urban adolescents suffer a disproportionate burden of asthma morbidity, often in association with allergies. Literature is limited on comparing various types of allergies regarding prevalence and associations with asthma morbidity in urban dwelling adolescents. The purpose of this study was to examine the prevalence of common allergies reported by urban adolescents and to assess their relationships to healthcare utilization and asthma control.

Association Between Use of Acid-Suppressive Medications and Antibiotics During Infancy and Allergic Diseases in Early Childhood

Edward Mitre, MD1; Apryl Susi, MS2; Laura E. Kropp, MPH1; et alDavid J. Schwartz, MD3; Gregory H. Gorman, MD2; Cade M. Nylund, MD2

JAMA Pediatr. 2018;172(6):e180315. doi:10.1001/jamapediatrics.2018.0315

Key Points

Question Does use of medications that disturb the microbiome in infancy increase subsequent risk of developing allergic diseases?

Findings In this cohort study of 792 130 children, the hazard of developing an allergic disease was significantly increased in those who had received acid-suppressive medications or antibiotics during the first 6 months of life.

Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab–clinical characteristics and treatment

September–October, 2018Volume 6, Issue 5, Pages 1778–1780.e1

Andreas Wollenberg, MD, PhDCorrespondence information about the author MD, PhD Andreas WollenbergEmail the author MD, PhD Andreas Wollenberg

, 

Lieneke Ariens, MD

, 

Stephan Thurau, MD, PhD

, 

Chantal van Luijk, MD

, 

Marlene Seegräber, MD

, 

Marjolein de Bruin-Weller, MD, PhD

Open Access

PlumX Metrics

DOI: https://doi.org/10.1016/j.jaip.2018.01.034

 

Article Info

Treatment with the SQ house dust mite sublingual immunotherapy tablet may be initiated year-round

September–October, 2018Volume 6, Issue 5, Pages 1758–1760.e1

Correspondence information about the author MD, PhD Hendrik Nolt

Email the author MD, PhD Hendrik Nolte

Hendrik Nolte, MD, PhD

David I. Bernstein, MD, FAAAAI

, 

Jörg Kleine-Tebbe, MD, FAAAAI

, 

Peter A. Fejerskov, RN, BSN

, 

Qing Li, PhD

, 

Susan Lu, PharmD

, 

Harrold S. Nelson, MD, FAAAAI

Open Access

PlumX Metrics

DOI: https://doi.org/10.1016/j.jaip.2017.12.035

Article Info

Value of a Second Dose of Epinephrine During Anaphylaxis: A Patient/Caregiver Survey

September–October, 2018Volume 6, Issue 5, Pages 1559–1567

T. Ted Song, DOCorrespondence information about the author DO T. Ted SongEmail the author DO T. Ted Song

, 

Duncan Brown, PhD

, 

Martin Karjalainen, MD

, 

Ulrike Lehnigk, PhD

, 

Phil Lieberman, MD

Open Access

PlumX Metrics

DOI: https://doi.org/10.1016/j.jaip.2018.01.019

 |

Article Info

• Abstract

• Full Text
• Images
• References
• Supplemental Materials

Background

Anaphylaxis guidelines recommend prescription of more than 1 epinephrine autoinjector (EAI) for patients at risk. A second epinephrine dose is required in 16% to 36% of patients.

Prevalence of allergic sensitization, hay fever, eczema, and asthma in a longitudinal birth cohort

ORIGINAL RESEARCH

          

• Abstract
• Fulltext
• Metrics
• Get Permission

Authors Owens L, Laing IA, Zhang G, Turner S, Le Souëf PN

Received 9 April 2018

Accepted for publication 4 May 2018

Published 13 August 2018 Volume 2018:11 Pages 173—180

DOI https://doi.org/10.2147/JAA.S170285

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Colin Mak

Peer reviewer comments 2

Editor who approved publication: Dr Luis Garcia-Marcos

Louisa Owens,^1,2 Ingrid A Laing,^3,4 Guicheng Zhang,^5,6 Stephen Turner,⁷ Peter N Le Souëf<sup>1

1</sup>School of Medicine, University of Western Australia, Perth, WA, Australia; ²School of Women’s and Children’s Health, University of New South Wales, Sydney, NSW, Australia; ³Telethon Kids Institute, Perth, WA, Australia; ⁴School of Biomedical Sciences, University of Western Australia, Perth, WA, Australia; ⁵School of Public Health, Curtin University, Perth, WA, Australia; ⁶Centre for Genetic Origins of Health and Disease, University of Western Australia, Perth, WA, Australia; ⁷School of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, UK

Effects of nasal dilator strips on subjective measures of sleep in subjects with chronic nocturnal nasal congestion: a randomized, placebo-controlled trial

Allergy, Asthma & Clinical Immunology

                 
• Research
• Open Access

• Eric J. SchenkelEmail author,
• Renee Ciesla and
• Gilbert Marava Shanga

Allergy, Asthma & Clinical Immunology201814:34

Abstract

Background

This exploratory study investigated effects of a new asymmetric butterfly-shaped prototype nasal dilator strip and the currently marketed clear Breathe Right Nasal Strip (BRNS) on subjective measures of nasal congestion and sleep quality.

The Role of Interleukin-19 in Contact Hypersensitivity.

Fujimoto Y, et al. Biol Pharm Bull. 2018.

Show full citation

Abstract

Interleukin (IL)-19 is a member of the IL-10 family of interleukins and is an immuno-modulatory cytokine produced by the main macrophages. The gastrointestinal tissues of IL-19 knockout mice show exacerbated experimental colitis mediated by the innate immune system and T cells.